Role of mTOR downstream effector signaling molecules in Francisella tularensis internalization by murine macrophages

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Edwards, Michael W ^b   Aultman, James A ^a   Harber, Gregory ^b   Bhatt, Jay M ^c   Sztul, Elizabeth ^c   Xu, Qingan ^b,d   Zhang, Ping ^a   Michalek, Suzanne M ^b   Katz, Jannet ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C GAMMA1; PROTEIN KINASE B; TOLL LIKE RECEPTOR 2; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ARTICLE; BACTERIAL INFECTION; CALCIUM SIGNALING; CELL COUNT; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; FRANCISELLA TULARENSIS; HOST CELL; INTERNALIZATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CONFOCAL MICROSCOPY; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; MICROBIOLOGY; PATHOGENICITY;

ANIMALS; CELLS, CULTURED; FRANCISELLA TULARENSIS; IMMUNOPRECIPITATION; MACROPHAGES; MICE; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84891618902     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083226     Document Type: Article

References (88)

1. Oyston PCF, Sjostedt A, Titball RW (2004) Tularemia: bioterrorism defence renews interest in Francisella tularensis. Nat Rev Microbiol 2: 967-978. doi:10.1038/nrmicro1045. PubMed: 15550942.
2. Santic M, Al-Khodor S, Kwaik YA (2010) Cell biology and molecular ecology of Francisella tularensis. Cell Microbiol 12: 129-139. doi: 10.1111/j.1462-5822.2009.01400.x. PubMed: 19863554.
3. Clemens DL, Horwitz MA (2007) Uptake and intracellular fate of Francisella tularensis in human macrophages. Ann N Y Acad Sci 1105: 160-186. doi:10.1196/annals.1409.001. PubMed: 17435118.
4. Long GW, Oprandy R, Narayanan RB, Fortier AH, Porter KR et al. (1993) Detection of Francisella tularensis in blood by polymerase chain reaction. J Clin Microbiol 31: 152-154. PubMed: 8417022.
5. Elkins KL, Cowley SC, Bosio CM (2003) Innate and adaptive immune responses to an intracellular bacterium Francisella tularensis live vaccine strain. Microbes Infect 5: 135-142. doi:10.1016/S1286-4579(02)00084-9. PubMed: 12650771.
6. May RC, Machesky LM (2001) Phagocytosis and the actin cytoskeleton. J Cell Sci 114: 1061-1077. PubMed: 11228151.
7. Parsa KVL, Butchar JP, Rajaram MVS, Cremer TJ, Tridandapani S (2008) The tyrosine kinase Syk promotes phagocytosis of Francisellathrough the activation of Erk. Mol Immunol 45: 3012-3021. doi:10.1016/j.molimm.2008.01.011. PubMed: 18295889.
8. Leinweber BD, Leavis PC, Grabarek Z, Wang C-LA, Morgan KG (1999) Extracellular regulated kinase (ERK) interaction with actin and the calponin homology (CH) domain of actin-binding proteins. Biochem J 344: 117-123. doi:10.1042/0264-6021:3440117. PubMed: 10548541.
9. Crowley MT, Costello PS, Fitzer-Attas CJ, Turner M, Meng F et al. (1997) A critical role for Syk in signal transduction and phagocytosis mediated by Fcγ receptors on macrophages. J Exp Med 186:1027-1039. doi:10.1084/jem.186.7.1027. PubMed: 9314552.
10. Martin TF (1998) Phosphoinositide lipids as signaling molecules: common themes for signal transduction, cytoskeletal regulation, and membrane trafficking. Annu Rev Cell Dev Biol 14: 231-264. doi: 10.1146/annurev.cellbio. 14.1.231. PubMed: 9891784.
11. Ip CKM, Wong AST (2012) p70 S6 kinase and actin dynamics. Spermatogenesis 2: 1-9. doi:10.4161/spmg.19885. PubMed: 22553484.
12. Jacinto E, Loewith R, Schmidt A, Lin S, Rüegg MA et al. (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 6: 1122-1128. doi:10.1038/ncb1183. PubMed: 15467718.
13. Sarbassov DD, Ali SM, Kim D-H, Guertin DA, Latek RR et al. (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14: 1296-1302. doi:10.1016/j.cub.2004.06.054. PubMed: 15268862.
14. Botelho RJ, Teruel M, Dierckman R, Anderson R, Wells A et al. (2000) Localized biphasic changes in phosphatidylinositol-4,5-biphosphate at sites of phagocytosis. J Cell Biol 151: 1353-1368. doi:10.1083/jcb.151.7.1353. PubMed: 11134066.
15. Sukumaran SK, McNamara G, Prasadarao NV (2003) Escherichia coliK-1 interaction with human brain micro-vascular endothelial cells triggers phospholipase C-γ1 activation downstream ofphosphatidylinositol 3-kinase. J Biol Chem 278: 45753-45762. doi: 10.1074/jbc.M307374200. PubMed: 12952950.
16. Sukumaran SK, Prasadarao NV (2002) Regulation of protein kinase C in Escherichia coli K1 invasion of human brain microvascular endothelial cells. J Biol Chem 277: 12253-12262. doi:10.1074/jbc.M110740200. PubMed: 11805101.
17. Markova B, Albers C, Breitenbuecher F, Melo JV, Brümmendorf TH et al. (2010) Novel pathway in Bcr-Abl signal transduction involves Akt-independent, PLC-γ1-driven activation of mTOR/p70S6-kinasepathway. Oncogene 29: 739-751. doi:10.1038/onc.2009.374. PubMed: 19881535.
18. Oshiro N, Yoshino K-I, Hidayat S, Tokunaga C, Hara K et al. (2004) Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function. Genes Cells 9: 359-366. doi: 10.1111/j.1356-9597.2004.00727.x. PubMed: 15066126.
19. Raught B, Gingraas AC, Sonenberg N (2001) The target of rapamycin (TOR). Proteins - Proc Natl Acad Sci U-S-A 98: 7037-7044. doi: 10.1073/pnas.121145898.
20. Sarbassov DD, Ali SM, Sabatini DM (2005) Growing roles for the mTOR pathway. Curr Opin Cell Biol 17: 596-603. doi:10.1016/j.ceb.2005.09.009. PubMed: 16226444.
21. Schmelzle T, Hall MN (2000) TOR, a central controller of cell growth. Cell 103: 253-262. doi:10.1016/S0092-8674(00)00117-3. PubMed: 11057898.
22. Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124: 471-484. doi:10.1016/j.cell.2006.01.016. PubMed: 16469695.
23. Coombes BK, Mahony JB (2002) Identification of MEK- and phosphoinositide 3-kinase-dependent signaling as essential events during Chlamydia pneumoniae invasion of HEp2 cells. Cell Microbiol 4: 447-460. doi:10.1046/j.1462-5822.2002. 00203.x. PubMed: 12102690.
24. Kierbel A, Gassama-Diagne A, Mostov K, Engel JN (2005) The phosphoinositol-3-kinase-protein kinase B/Akt pathway is critical for Pseudomonas aeruginosa strain PAK internalization. Mol Biol Cell 16: 2577-2585. doi:10.1091/mbc.E04-08-0717. PubMed: 15772151.
25. Ohira T, Arita M, Omori K, Recchiuti A, Van Dyke TE et al. (2010) Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J Biol Chem 285: 3451-3461. doi:10.1074/jbc.M109.044131. PubMed: 19906641.
26. Chen J, Zheng XF, Brown EJ, Schreiber SL (1995) Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin- associated protein and characterization of a critical serine residue. Proc Natl Acad Sci U S A 92: 4947-4951. doi:10.1073/pnas.92.11.4947. PubMed: 7539137.
27. Huang S, Bjornsti M-A, Houghton PJ (2003) Rapamycins: mechanism of action and cellular resistance. Cancer Biol Ther 2: 222-232. PubMed: 12878853.
28. Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR et al. (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110: 163-175. doi:10.1016/S0092-8674(02)00808-5. PubMed: 12150925.
29. Hara K, Maruki Y, Long X, Yoshino K, Oshiro N et al. (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110: 177-189. doi:10.1016/S0092-8674(02)00833-4. PubMed: 12150926.
30. Nojima H, Tokunaga C, Eguchi S, Oshiro N, Hidayat S et al. (2003) The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS). Motif - J Biol Chem 278: 15461-15464. doi:10.1074/jbc.C200665200.
31. Sarbassov DD, Ali SM, Sengupta S, Sheen J-H, Hsu PP et al. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 22: 159-168. doi:10.1016/j.molcel.2006.03.029. PubMed: 16603397.
32. Ireton K, Payrastre B, Chap H, Ogawa W, Sakaue H et al. (1996) A role for phosphoinositide 3-kinase in bacterial invasion. Science 274: 780-782. doi:10.1126/science.274.5288.780. PubMed: 8864117.
33. Kwok T, Backert S, Schwarz H, Berger J, Meyer TF (2002) Specific entry of Helicobacter pylori into cultured gastric, epithelial cells via a zipper-like mechanism. Infect Immun 70: 2108-2120. doi:10.1128/IAI.70.4.2108-2120.2002. PubMed: 11895977.
34. Reddy MA, Prasadarao NV, Wass CA, Kim KS (2000) Phosphatidylinositol 3-kinase activation and interaction with focal adhesion kinase in Escherichia coli K1 invasion of human brain microvascular endothelial cells. J Biol Chem 275: 36769-36774. doi: 10.1074/jbc.M007382200. PubMed: 10973983.
35. Rameh LE, Rhee SG, Spokes K, Kazlauskas A, Cantley LC et al. (1998) Phosphoinositide 3-kinase regulates phospholipase C-γ mediated calcium signaling. J Biol Chem 273: 23750-23757. doi: 10.1074/jbc.273.37.23750. PubMed: 9726983.
36. 411 in vascular smooth muscle cells. J Biol Chem 274: 36843-36851. doi:10.1074/jbc.274.52.36843. PubMed: 10601235.
37. Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP (2005) Phosphorylation and functional inactivation of TSC2 by Erk: Implications for tuberous sclerosis and cancer pathogenesis. Cell 121: 179-193. doi:10.1016/j.cell.2005.02.031. PubMed: 15851026.
38. S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6. J Biol Chem 277: 15712-15720. doi:10.1074/jbc.M200043200. PubMed: 11872747.
39. Tokuda H, Hatakeyama D, Shibata T, Akamatsu S, Oiso Y et al. (2003) p38 MAP kinase regulates BMP-4-stimulated VEGF synthesis via p70 S6 kinase in osteoblasts. Am J Physiol Endocrinol Metab 284: E1202-E1209. PubMed: 12637256.
40. Wang X, Flynn A, Waskiewicz AJ, Webb BLJ, Vries RG et al. (1998) The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways. J Biol Chem 273: 9373-9377. doi:10.1074/jbc.273.16.9373. PubMed: 9545260.
41. Elkins KL, Winegar RK, Nacy CA, Fortier AH (1992) Introduction of Francisella tularensis at skin sites induces resistance to infection and generation of protective immunity. Microb Pathog 13: 417-421. doi: 10.1016/0882-4010(92)90085-3. PubMed: 1297917.
42. Katz J, Zhang P, Martin M, Vogel SN, Michalek SM (2006) Toll-like receptor 2 is required for inflammatory responses to Francisellatularensis LVS. Infect Immun 74: 2809-2816. doi:10.1128/IAI.74.5.2809-2816.2006. PubMed: 16622218.
43. Zhang P, Katz J, Michalek SM (2009) Glycogen synthase kinase-3β(GSK3β) inhibition suppresses the inflammatory response toFrancisella infection and protects against tularemia in mice. Mol Immunol 46: 677-687. doi:10.1016/j.molimm.2008.08.281. PubMed: 18929413.
44. Zhang P, Martin M, Michalek SM, Katz J (2005) Role of mitogen-activated protein kinases and NF-κB in the regulation ofproinflammatory and anti-inflammatory cytokines by Porphyromonasgingivalis hemagglutinin B. Infect Immun 73: 3990-3998. doi:10.1128/IAI.73.7.3990-3998.2005. PubMed: 15972486.
45. - double negative T cells are prominent producers of IL-17A and IFN-γ during primary respiratory murine infection withFrancisella tularensis Live Vaccine Strain. J Immunol 184: 5791-5801. doi:10.4049/jimmunol.1000362. PubMed: 20393138.
46. Hazlett KRO, Caldon SD, McArthur DG, Cirillo KA, Kirimanjeswara GS et al. (2008) Adaptation of Francisella tularensis to the mammalian environment is governed by cues which can be mimicked in vitro. Infect Immun 76: 4479-4488. doi:10.1128/IAI.00610-08. PubMed: 18644878.
47. Loegering DJ, Drake JR, Banas JA, McNealy TL, Mc Arthur DG et al. (2006) Francisella tularensis LVS grown in macrophages has reduced ability to stimulate the secretion of inflammatory cytokines by macrophages in vitro. Microb Pathog 41: 218-225. doi:10.1016/j.micpath.2006.07.007. PubMed: 16996713.
48. Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18: 1926-1945. doi:10.1101/gad.1212704. PubMed: 15314020.
49. Inoki K, Guan KL (2006) Complexity of the TOR signaling network. Trends Cell Biol 16: 206-212. doi:10.1016/j.tcb.2006.02.002. PubMed: 16516475.
50. Gingras A-C, Gygi SP, Raught B, Polakiewics RD, Abraham RT et al. (1999) Regulation of 4E-BP1 phosphorylation : A novel two step mechanism. Genes and Dev 13: 1422-1437. doi:10.1101/gad.13.11.1422.
51. Gingras A-C, Raught B, Gygi SP, Niedzwiecka A, Miron M et al. (2001) Hierarchical phosphorylation of the translational inhibitor 4E-BP1. Genes and Dev 15: 2852-2864.
52. Pyronnet S (2000) Phosphorylation of the cap-binding protein eIF4E by the MAPK-activated protein kinase Mnk1. Biochem Pharmacol 60: 1237-1243. doi:10.1016/S0006-2952(00)00429-9. PubMed: 11007962.
53. Corradetti MN, Guan K-L (2006) Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 25: 6347-6360. doi:10.1038/sj.onc.1209885. PubMed: 17041621.
54. Dann SG, Selvaraj A, Thomas G (2007) mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med 13: 252-259. doi:10.1016/j.molmed.2007.04.002. PubMed: 17452018.
55. Schmitz F, Heit A, Dreher S, Eisenächer K, Mages J et al. (2008) Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. Eur J Immunol 38: 2981-2992. doi: 10.1002/eji.200838761. PubMed: 18924132.
56. Chen X-G, Liu F, Song X-F, Wang Z-H, Dong Z-Q et al. (2010) Rapamycin regulates Akt and ERK phosphorylation through mTORC1 and mTORC2 signaling pathways. Mol Carcinog 49: 603-610. PubMed: 20512842.
57. Li Q, Zhao WD, Zhang K, Fang WG, Hu Y et al. (2010) PI3K-dependent host cell actin rearrangements are required for Cronobacter sakazakiiinvasion of human brain microvascular endothelial cells. Med Microbiol Immunol 199: 333-340. doi:10.1007/s00430-010-0168-8. PubMed: 20809254.
58. Gulhati P, Bowen KA, Liu J, Stevens PD, Rychahow PG et al. (2011) mTORC1 and mTORC2 regulate EMT, motility and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res 7: 3246-3256.
59. Wong R, Fabian L, Forer A, Brill JA (2007) Phospholipase C and myosin light chain kinase inhibition define a common step in actin regulation during cytokinesis. BMC Cell Biol 8: 15-24. doi: 10.1186/1471-2121-8-15. PubMed: 17509155.
60. Kim MJ, Kim E, Ryu SH, Suh P-G (2000) The mechanism of phospholipase Cγ1 regulation. Exp Mol Med 32: 101-109. doi:10.1038/emm.2000.18. PubMed: 11048639.
61. Rebecchi MJ, Pentyala SN (2000) Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev 80: 1291-1335. PubMed: 11015615.
62. Guay J, Lambert H, Gingras-Breton G, Lavoie JN, Huot J et al. (1997) Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J Cell Sci 110: 357-368. PubMed: 9057088.
63. Rydkina E, Turpin LC, Sahni SK (2008) Activation of p38 mitogen-activated protein kinase module facilitates in vitro host cell invasion by Rickettsia rickettsii. J Med Microbiol 57: 1172-1175. doi:10.1099/jmm.0.47806-0. PubMed: 18719192.
64. Weng QP, Andrabi K, Kozlowski MT, Grove JR, Avruch J (1995) Multiple independent inputs are required for activation of p70 S6 kinase. Mol Cell Biol 15: 2333-2340. PubMed: 7739516.
65. Li H, Nookala S, Bina RX, Bina JE et al. (2006) Innate immune response to Francisella tularensis is mediated by TLR2 and caspase-1 activation. J Leukoc Biol 80: 766-773. doi:10.1189/jlb.0406294. PubMed: 16895974.
66. S6K pathway in regulating the actin cytoskeleton and cell migration. Exp Cell Res 296: 183-195. doi:10.1016/j.yexcr.2003.12.032. PubMed: 15149849.
67. Ip CKM, Cheung ANY, Ngan HYS, Wong AST (2011) p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells. Oncogene 30: 2420-2432. doi:10.1038/onc.2010.615. PubMed: 21258406.
68. Liu L, Chen L, Chung J, Huang S (2008) Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins. Oncogene 27: 4998-5010. doi:10.1038/onc.2008.137. PubMed: 18504440.
69. Ganesan LP, Wei R, Pengal RA, Moldovan L, Moldovan N et al. (2004) The serine/threonine kinase Akt promotes Fcγ receptor-mediatedphagocytosis in murine macrophages through the activation of p70S6 kinase. J Biol Chem 279: 54416-54425. doi:10.1074/jbc.M408188200. PubMed: 15485887.
70. Wlodarski P, Kasprzycka M, Liu X, Marzec M, Robertson ES et al. (2005) Activation of mammalian target of rapamycin in transformed B lymphocytes in nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum. Cancer Res 65: 7800-7808. PubMed: 16140948.
71. Arvisais EW, Romanelli A, Hou X, Davis JS (2006) AKT-independent phosphorylation of TSC2 and activation of mTOR and ribosomal protein S6 kinase signaling by prostaglandin F2α. J Biol Chem 28:26904-26913.
72. Genolet R, Araud T, Maillard L, Jaquier-Gubler P, Curran J (2008) An approach to analyse the specific impact of rapamycin on mRNA-ribosome association. BMC Med Genomics 1: 33-44. doi: 10.1186/1755-8794-1-33. PubMed: 18673536.
73. Biondi RM, Kieloch A, Currie RA, Deak M, Alessi DR (2001) The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB. EMBO J 20: 4380-4390. doi:10.1093/emboj/20.16.4380. PubMed: 11500365.
74. S6K following exposure to UVA irradiation. J Biol Chem 276: 20913-20923. doi:10.1074/jbc.M009047200. PubMed: 11279232.
75. Casas-Terradellas E, Tato I, Bartrons R, Ventura F, Rosa JL (2008) ERK and p38 pathways regulate amino acid signaling. Biochim Biophys Acta 1783: 2241-2254. doi:10.1016/j.bbamcr.2008.08.011. PubMed: 18809440.
76. Roux PP, Shahbazian D, Vu H, Holz MK, Cohen MS et al. (2007) RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates Cap-dependent translation. J Biol Chem 282: 14056-14064. doi:10.1074/jbc.M700906200. PubMed: 17360704.
77. +-glucose cotransport. J Biol Chem 281: 24247-24253. doi: 10.1074/jbc.M602898200. PubMed: 16793766.
78. Rane MJ, Coxon PY, Powell DW, Webster R, Klein JB et al. (2001) p38 kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils. J Biol Chem 276: 3517-3523. doi:10.1074/jbc.M005953200. PubMed: 11042204.
79. Menges CW, McCance DJ (2008) Constitutive activation of the Raf-MAPK pathway causes negative feedback inhibition of Ras-PI3K-Akt and cellular arrest through EphA2 receptor. Oncogene 27: 2934-2940. doi:10.1038/sj.onc.1210957. PubMed: 18059341.
80. Bulavin DV, Amundson SA, Fornace AJ (2002) p38 and Chk1 kinases: different conductors for the G(2)/M checkpoint symphony. Curr Opin Genet Dev 12: 92-97. doi:10.1016/S0959-437X(01)00270-2. PubMed: 11790561.
81. SAPK2- dependent manner. J Biol Chem 275: 35091-35097. doi:10.1074/jbc.M006324200. PubMed: 10952989.
82. Thornton TM, Rincon M (2009) Non-classical p38 map kinase functions: cell cycle checkpoints and survival. Int J Biol Sci 5: 44-51. PubMed: 19159010.
83. Lennartz MR (1999) Phospholipases and phagocytosis: the role of phospholipid-derived second messengers in phagocytosis. Int J Biochem Cell Biol 31: 415-430. doi:10.1016/S1357-2725(98)00108-3. PubMed: 10224668.
84. 2+ signaling in intracellular invasion of non-phagocytic host cells by Orientia tsutsugamushi. Microb Pathog 50: 326-330. doi:10.1016/j.micpath. 2011.02.007. PubMed: 21362468.
85. Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20: 197-216. doi:10.1146/annurev.immunol.20.083001.084359. PubMed: 11861602.
86. Doyle SE, O'Connell RM, Miranda GA, Vaidya SA, Chow EK et al. (2004) Toll-like receptors induce a phagocytic gene program through p38. J Exp Med 199: 81-90. PubMed: 14699082.
87. Neal MD, Leaphart C, Levy R, Prince J, Billiar TR et al. (2006) Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol 176: 3070-3079. PubMed: 16493066.
88. Luther K, Torosantucci A, Brakhage AA, Heesemann J, Ebel F (2007) Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition by the dectin-1 beta-glucan receptor and Toll-like receptor 2. Cell Microbiol 9: 368-381. doi:10.1111/j.1462-5822.2006.00796.x. PubMed: 16953804.